Carcinoma, Non-Small-Cell Lung: all 6,645 studies
Page 49 of 67. Open to participants first (1,667), then studies with results posted, then the rest; newest registration first within each.
- To Evaluate the Optimal Timing of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung CancerTerminatedNCT02974426Phase 3
- Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of Alflutinib in Advanced Non Small Cell Lung CancerTerminatedNCT02973763Phase 1
- Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790MStatus unknownNCT02972333Phase 3
- Post-marketing Surveillance Study of Docetaxel-Based ChemotherapyCompletedNCT02972216
- Clinical Study of YQ1 Plus Cisplatin-based Chemotherapy in Advanced NSCLC EGFR Wild TypeStatus unknownNCT02967497Phase 2
- N2 Lung Cancer Project: Neoadjuvant Treatment Followed Surgery Versus ChemoradiationCompletedNCT02966769
- Dynamic Changes of Circulating Tumor DNA in Surgical Lung Cancer PatientsCompletedNCT02965391
- Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC.CompletedNCT02964689Phase 1
- Study of ASN003 in Subjects With Advanced Solid TumorsTerminatedNCT02961283Phase 1
- Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR MutationStatus unknownNCT02961270Phase 2
- High-dose Icotinib Treatment Beyond Progression in EGFR Mutant NSCLCStatus unknownNCT02960607Phase 2
- Osimertinib or Docetaxel-bevacizumab as Third-line Treatment in EGFR T790M Mutated Non-Small Cell Lung CancerCompletedNCT02959749Phase 2/3
- Ensartinib in Non-small Cell Lung Cancer Patients With Positive ALKCompletedNCT02959619Phase 1
- Personalized DC Vaccine for Lung CancerStatus unknownNCT02956551Phase 1
- CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck CancerActive, not recruitingNCT02955290Phase 1/2
- A Safety Study of SGN-2FF for Patients With Advanced Solid TumorsTerminatedNCT02952989Phase 1
- Study of Antibody Drug Conjugate in Patients With Advanced Breast Cancer Expressing HER2CompletedNCT02952729Phase 1
- Effects of Acupuncture Stimulation on Systemic InflammationStatus unknownNCT02951611Not applicable
- MRI Adaptive Replanning Using ViewRayWithdrawnNCT02950792Not applicable
- Stereotactic Body Radiation Therapy for Un-biopsied Early- Stage Non Small Cell Lung CancerActive, not recruitingNCT02950337Not applicable
- Study of Ibrutinib Followed by Ibrutinib in Combination With Nivolumab in Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT02950038Phase 2
- Skeletal Muscle Atrophy and Dysfunction in Human CancerCompletedNCT02949076Not applicable
- Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung CancerCompletedNCT02947386Phase 1
- Combination of Platinum Doublets and Hypofractionated Radiotherapy in NSCLCWithdrawnNCT02947113Phase 2
- ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLCStatus unknownNCT02946216
- Study of Veliparib in Combination With Nivolumab and Platinum Doublet Chemotherapy in Participants With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT02944396Phase 1
- A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT02941601Phase 2
- Anti PD-1 Neo-adjuvant Treatment for NSCLCCompletedNCT02938624Phase 1
- 18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical StudyStatus unknownNCT02938546Phase 3
- Bronchoscopy With Bronchoalveolar Lavage in Identifying Biomarkers of Response to Immune Checkpoint Inhibitors in Patients With Non-small Cell or Small Cell Lung CancerTerminatedNCT02937402Not applicable
- TR(ACE) Assay Clinical Specimen StudyStatus unknownNCT02934360
- Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU ProgramCompletedNCT02933346
- Gefitinib Long-term Survivor StudyTerminatedNCT02932345
- Gefitinib Combined With Chemotherapy or Antiangiogensis in Patients With Bim Deletion or Low EGFR Mutation AbundanceStatus unknownNCT02930954Phase 2
- Safety, Efficacy and Pharmacokinetic of BPI-9016M in Patients With c-Met- Dysregulated Advanced NSCLCStatus unknownNCT02929290Phase 1
- A Study of Lorlatinib in Advanced ALK and ROS1 Rearranged Lung Cancer With CNS Metastasis in the Absence of Measurable Extracranial LesionsStatus unknownNCT02927340Phase 2
- Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid TumorsCompletedNCT02926768Phase 1
- Sym004 in Combination With Nivolumab Versus Nivolumab Monotherapy in EGFR-amplified Squamous Non-Small Cell Lung CancerWithdrawnNCT02924233Phase 1/2
- Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.CompletedNCT02922777Phase 1
- A Study of RGX-104 in Patients With Advanced Lung & Endometrial CancerCompletedNCT02922764Phase 1
- Detection of Circulating Biomarkers of Immunogenic Cell DeathCompletedNCT02921854Not applicable
- Open-label, Multicenter, Randomized Phase II Trial of Treatment With Cisplatin and Pemetrexed or Cisplatin and Oral Vinorelbine in Chemotherapy Naïve Patients Affected by Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer With High Thymidylate Synthase ExpressionTerminatedNCT02919462Phase 2
- An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung CancerCompletedNCT02917993Phase 1/2
- Effect of Different Anesthetics on the Change of Alarmins in Lung Cancer Patients Receiving Pulmonary LobectomyStatus unknownNCT02916147Not applicable
- Safety, Tolerability and Pharmacokinetic Profile of BPI-15086 in EGFR T790M Mutation-positive NSCLC PatientsCompletedNCT02914990Phase 1
- Suction on Post-Operative Chest TubesCompletedNCT02911259Not applicable
- Real-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior ChemotherapyCompletedNCT02910999
- Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid TumorsCompletedNCT02909452Phase 1
- Study to Assess the Effect of Osimertinib (TAGRISSO™ ) on Blood Levels of Fexofenadine in Patients With EGFRm+ NSCLCCompletedNCT02908750Phase 1
- Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective StudyStatus unknownNCT02907606
- Concordance of Inivata Liquid Biopsy With Standard of Care Tissue TestingCompletedNCT02906852
- First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care TherapyStatus unknownNCT02906163Phase 1/2
- Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild TypeStatus unknownNCT02906150Phase 2
- Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid TumorsCompletedNCT02897778Phase 1
- A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder CancerCompletedNCT02897765Phase 1
- Palbociclib With Cisplatin or Carboplatin in Advanced Solid TumorsCompletedNCT02897375Phase 1
- First-in-human Phase I Study of a Selective c-Met Inhibitor PLB1001CompletedNCT02896231Phase 1
- Microwave Ablation in the Treatment of Stage I Non Small Cell Lung CancerStatus unknownNCT02896166Phase 3
- Yoga in Improving Quality of Life in Patients With Non-small Cell Lung Cancer Undergoing TreatmentTerminatedNCT02895503Not applicable
- Lung Cancer Early Molecular Assessment TrialStatus unknownNCT02894853
- A Study of PDR001 in Combination With LCL161, Everolimus or PanobinostatCompletedNCT02890069Phase 1
- An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation StudyStatus unknownNCT02884479Phase 1/2
- First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR MutationStatus unknownNCT02883543Phase 3
- Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer PatientsCompletedNCT02879760Phase 1/2
- Efficacy-Safety-Immunogenicity Study of CBT124&EU-sourced Avastin® in Stage 4 NSCLCStatus unknownNCT02879097Phase 3
- EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion PolymorphismStatus unknownNCT02859077Phase 3
- A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic CancerCompletedNCT02857270Phase 1
- Therapeutic Resistance Prediction of Tyrosine Kinase InhibitorsStatus unknownNCT02851329
- Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung CancerCompletedNCT02848872
- A Positron Emission Tomography (PET) Imaging Agent [18F]-ODS2004436 as a Marker of EGFR Mutation in Subjects With NSCLCCompletedNCT02847377Not applicable
- Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung CancerCompletedNCT02845856Phase 1/2
- DE-CT in Lung Cancer Proton TherapyWithdrawnNCT02844140Not applicable
- Clinical Study of Ganoderma Lucidum Spore Combined With ChemotherapyStatus unknownNCT02844114Phase 2
- Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung CancerCompletedNCT02843815Phase 1/2
- Intensity-modulated Radiotherapy (IMRT) With Simultaneous Integrated Boost (SIB) for Inoperable Non-small-cell Lung CancerStatus unknownNCT02841228Phase 2
- A Trial of CV301 in Combination With Anti-PD-1 Therapy in Subjects With Non-Small Cell Lung CancerCompletedNCT02840994Phase 1
- Long-term Epidemiological Follow-up of Non-small Cell Lung Cancer in ScandinaviaCompletedNCT02839629
- Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).CompletedNCT02831959Phase 3
- A Study of Ramucirumab (LY3009806) in Combination With Weekly Docetaxel in Participants With Stage IV Non-Small Cell Lung CancerWithdrawnNCT02831491Phase 2
- PDL-1 Expression on Circulating Tumor Cells in Non-small Cell Lung CancerCompletedNCT02827344
- Pembrolizumab + CVA21 in Advanced NSCLCStatus unknownNCT02824965Phase 1
- Neo-adjuvant Trial With AZD9291 in EGFRm+ Stage IIIA/B NSCLCStatus unknownNCT02824952Phase 2
- A Study of Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR MutationsStatus unknownNCT02824458Phase 3
- Crizotinib Expanded Access Protocol For ROS1 Positive NSCLCNo longer availableNCT02824094
- Parametric Imaging in Positron Emission Tomography for Patient With Lung CancerCompletedNCT02821936Not applicable
- The Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR MutationStatus unknownNCT02820116Phase 2
- Universal Cancer Peptide-based Vaccination in Metastatic NSCLCCompletedNCT02818426Phase 1/2
- A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)Active, not recruitingNCT02817633Phase 1
- Chidamide With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung CancerStatus unknownNCT02815007Phase 2
- A Study of Atezolizumab Compared With Docetaxel in Non-Small Cell Lung Cancer (NSCLC) After Failure With Platinum-Containing ChemotherapyCompletedNCT02813785Phase 3
- Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT02812667Phase 1
- Phase II Study of AZD9291 in Advanced Stage NSCLC With EGFR and T790M Mutations Detected in Plasma Ct-DNAStatus unknownNCT02811354Phase 2
- Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung CarcinomaCompletedNCT02805530Not applicable
- Acquired Resistant Mechanism of the First-generation EGFR TKIsStatus unknownNCT02804217
- Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC PatientsStatus unknownNCT02804100
- A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal MetastasisStatus unknownNCT02803619
- Oncology Research Information Exchange Network (ORIEN) Lung Cancer StudyCompletedNCT02803333
- Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer PatientsStatus unknownNCT02802540Phase 2/3
- Nab-Paclitaxel in Combination With Carboplatin as First-line Therapy in Patients With NSCLCCompletedNCT02799862
- Assessing the Efficacy and Safety of Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer Receiving Definitive ChemoradiotherapyActive, not recruitingNCT02788461Not applicable